ALKEM LABORATORIES
|
The Current P/E Ratio of ALKEM LABORATORIES is 28.50.
| Share Price | ₹5,746.0 | Jan 23,2026 |
| Market Cap | ₹68,722.2 Cr | |
| Earnings-TTM | ₹2,411.7 Cr | TTM-Consolidated Results |
| Price/Earnings | 28.50x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALKEM LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹68,722.2 Cr] as on Jan 23,2026
(/) Earnings [ ₹2,411.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 28.50x ]
Thus, for ALKEM LABORATORIES , the investors are currently willing to pay 28.50 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALKEM LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALKEM LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ALKEM LABORATORIES
PE Ratio Performance Analysis for ALKEM LABORATORIES
- ALKEM LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 29.66x.
- ALKEM LABORATORIES 's operated at median p/e ratio of 26.94x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALKEM LABORATORIES 's p/e ratio peaked in Mar2023 at 41.27x.
- ALKEM LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 20.91x.
How does ALKEM LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALKEM LABORATORIES | 2,411.72 | 28.50 | 68,722.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 37.22 | 391,488.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 64.15 | 159,415.0 |
| CIPLA LTD | 4,544.70 | 23.37 | 106,210.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 62.11 | 132,906.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 18.71 | 103,089.0 |
| MANKIND PHARMA LTD | 1,767.06 | 49.12 | 86,802.6 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 17.84 | 88,744.8 |
| LUPIN LTD | 4,347.53 | 22.46 | 97,624.8 |
| AUROBINDO PHARMA LTD | 3,447.75 | 19.09 | 65,813.5 |
| ABBOTT INDIA LTD | 1,508.95 | 39.19 | 59,136.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALKEM LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.84x |
| Max industry PE | 64.15x |
| Median industry PE | 28.50x |
| Average industry PE | 34.71x |
You may also like the below Video Courses